Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, S. M.
Right arrow Articles by Sidransky, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, S. M.
Right arrow Articles by Sidransky, D.
Clinical Cancer Research Vol. 7, 1982-1986, July 2001
© 2001 American Association for Cancer Research

Regular Articles

Promoter Hypermethylation of Multiple Genes in Carcinoma of the Uterine Cervix1

Seung Myung Dong, Hy-Sook Kim, Seo-Hee Rha and David Sidransky2

Department of Otolaryngology-Head and Neck Surgery, Head and Neck Cancer Research Division, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205-2196 [S. M. D., S-H. R., D. S.]; Department of Pathology, Samsung Cheil Hospital, Sungkyunkwan University School of Medicine, Seoul 100-380, Korea [H-S. K.]; and Department of Pathology, Dong-A University College of Medicine, Pusan 602-103, Korea [S-H. R.]

Promoter hypermethylation is an important pathway for the repression of gene transcription in cancer. We investigated promoter hypermethylation of six genes, p16, APC, HIC-1, death-associated protein kinase (DAPK), O6-methylguanine-DNA-methyltransferase (MGMT), and E-cadherin, in uterine cervical carcinoma from 53 patients including 31 cases of squamous cell carcinoma (SCC) and 22 cases of adenocarcinoma (AC). Aberrant methylation of at least one of these genes was detected in 79% (42 of 53) of cases including 71% (22 of 31) of SCC and 91% (20 of 22) of AC cases. No aberrant methylation was detected in normal cervical tissue from 24 control hysterectomy specimens. There was no correlation between promoter hypermethylation at any gene and the presence of human papillomavirus-16 or -18 E7 DNA. In AC cases, promoter hypermethylation of the APC and HIC-1 genes was detected at a statistically significant higher frequency than in the SCC cases (APC, 60% versus 13%, P < 0.001; HIC-1, 63% versus 32%, P < 0.03). Conversely, promoter hypermethylation of p16 and DAPK was more common in SCC cases than in AC cases. Our results suggest that promoter hypermethylation is a frequent epigenetic event in cervical carcinoma. The pattern of gene promoter hypermethylation is distinctly different between AC and SCC. The absence of these epigenetic alterations in normal cervical tissue suggests that they may also be valuable as cancer markers.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
S. S. Wang, D. J. Smiraglia, Y.-Z. Wu, S. Ghosh, J. S. Rader, K. R. Cho, T. A. Bonfiglio, R. Nayar, C. Plass, and M. E. Sherman
Identification of Novel Methylation Markers in Cervical Cancer Using Restriction Landmark Genomic Scanning
Cancer Res., April 1, 2008; 68(7): 2489 - 2497.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y. Kanai and S. Hirohashi
Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state
Carcinogenesis, December 1, 2007; 28(12): 2434 - 2442.
[Abstract] [Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
J. K. Stephen, L. E. Vaught, K. M. Chen, V. Shah, V. G. Schweitzer, G. Gardner, M. S. Benninger, and M. J. Worsham
An Epigenetically Derived Monoclonal Origin for Recurrent Respiratory Papillomatosis
Arch Otolaryngol Head Neck Surg, July 1, 2007; 133(7): 684 - 692.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Q. Yang, C. M. Kiernan, Y. Tian, H. R. Salwen, A. Chlenski, B. A. Brumback, W. B. London, and S. L. Cohn
Methylation of CASP8, DCR2, and HIN-1 in Neuroblastoma Is Associated with Poor Outcome
Clin. Cancer Res., June 1, 2007; 13(11): 3191 - 3197.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. Zhang, Z. Li, Y. Cheng, F. Jia, R. Li, M. Wu, K. Li, and L. Wei
CpG Island Methylator Phenotype Association with Elevated Serum {alpha}-Fetoprotein Level in Hepatocellular Carcinoma
Clin. Cancer Res., February 1, 2007; 13(3): 944 - 952.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. D. Williams, N. Chakravarti, M. S. Kies, S.-I. Maruya, J. N. Myers, J. C. Haviland, R. S. Weber, R. Lotan, and A. K. El-Naggar
Implications of Methylation Patterns of Cancer Genes in Salivary Gland Tumors
Clin. Cancer Res., December 15, 2006; 12(24): 7353 - 7358.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
V. V. Murty and G. Narayan
Re: Detection of Hypermethylated Genes in Women With and Without Cervical Neoplasia
J Natl Cancer Inst, October 19, 2005; 97(20): 1548 - 1548.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
J. M. Teodoridis, J. Hall, S. Marsh, H. D. Kannall, C. Smyth, J. Curto, N. Siddiqui, H. Gabra, H. L. McLeod, G. Strathdee, et al.
CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer
Cancer Res., October 1, 2005; 65(19): 8961 - 8967.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
M. O. Hoque, O. Topaloglu, S. Begum, R. Henrique, E. Rosenbaum, W. Van Criekinge, W. H. Westra, and D. Sidransky
Quantitative Methylation-Specific Polymerase Chain Reaction Gene Patterns in Urine Sediment Distinguish Prostate Cancer Patients From Control Subjects
J. Clin. Oncol., September 20, 2005; 23(27): 6569 - 6575.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Zhang, C. R. Martins, Z. B. Fansler, K. L. Roemer, E. A. Kincaid, K. S. Gustafson, D. F. Heitjan, and D. P. Clark
DNA Methylation in Anal Intraepithelial Lesions and Anal Squamous Cell Carcinoma
Clin. Cancer Res., September 15, 2005; 11(18): 6544 - 6549.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Uren, S. Fallen, H. Yuan, A. Usubutun, T. Kucukali, R. Schlegel, and J. A. Toretsky
Activation of the Canonical Wnt Pathway during Genital Keratinocyte Transformation: A Model for Cervical Cancer Progression
Cancer Res., July 15, 2005; 65(14): 6199 - 6206.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
N Murphy, M Ring, C C B B Heffron, B King, A G Killalea, C Hughes, C M Martin, E McGuinness, O Sheils, and J J O'Leary
p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer
J. Clin. Pathol., May 1, 2005; 58(5): 525 - 534.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
C D E Margetts, D Astuti, D C Gentle, W N Cooper, A Cascon, D Catchpoole, M Robledo, H P H Neumann, F Latif, and E R Maher
Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas
Endocr. Relat. Cancer, March 1, 2005; 12(1): 161 - 172.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
Q. Feng, A. Balasubramanian, S. E. Hawes, P. Toure, P. S. Sow, A. Dem, B. Dembele, C. W. Critchlow, L. Xi, H. Lu, et al.
Detection of Hypermethylated Genes in Women with and Without Cervical Neoplasia
J Natl Cancer Inst, February 16, 2005; 97(4): 273 - 282.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. M. Lewis, L. R. Cler, D.-W. Bu, S. Zochbauer-Muller, S. Milchgrub, E. Z. Naftalis, A. M. Leitch, J. D. Minna, and D. M. Euhus
Promoter Hypermethylation in Benign Breast Epithelium in Relation to Predicted Breast Cancer Risk
Clin. Cancer Res., January 1, 2005; 11(1): 166 - 172.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
W.-C. Xue, K. Y.K. Chan, H.-C. Feng, P.-M. Chiu, H. Y.S. Ngan, S.-W. Tsao, and A. N.Y. Cheung
Promoter Hypermethylation of Multiple Genes in Hydatidiform Mole and Choriocarcinoma
J. Mol. Diagn., November 1, 2004; 6(4): 326 - 334.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Parrella, M. L. Poeta, A. P. Gallo, M. Prencipe, M. Scintu, A. Apicella, R. Rossiello, G. Liguoro, D. Seripa, C. Gravina, et al.
Nonrandom Distribution of Aberrant Promoter Methylation of Cancer-Related Genes in Sporadic Breast Tumors
Clin. Cancer Res., August 15, 2004; 10(16): 5349 - 5354.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Dulaimi, I. I. de Caceres, R. G. Uzzo, T. Al-Saleem, R. E. Greenberg, T. J. Polascik, J. S. Babb, W. E. Grizzle, and P. Cairns
Promoter Hypermethylation Profile of Kidney Cancer
Clin. Cancer Res., June 15, 2004; 10(12): 3972 - 3979.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Widschwendter, C. Gattringer, L. Ivarsson, H. Fiegl, A. Schneitter, A. Ramoni, H. M. Muller, A. Wiedemair, S. Jerabek, E. Muller-Holzner, et al.
Analysis of Aberrant DNA Methylation and Human Papillomavirus DNA in Cervicovaginal Specimens to Detect Invasive Cervical Cancer and Its Precursors
Clin. Cancer Res., May 15, 2004; 10(10): 3396 - 3400.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
N. Reesink-Peters, G. B. A. Wisman, C. Jeronimo, C. Y. Tokumaru, Y. Cohen, S. M. Dong, H. G. Klip, H. J. Buikema, A. J.H. Suurmeijer, H. Hollema, et al.
Detecting Cervical Cancer by Quantitative Promoter Hypermethylation Assay on Cervical Scrapings: A Feasibility Study
Mol. Cancer Res., May 1, 2004; 2(5): 289 - 295.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. C. Lindsey, M. E. Lusher, J. A. Anderton, S. Bailey, R. J. Gilbertson, A. D.J. Pearson, D. W. Ellison, and S. C. Clifford
Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling
Carcinogenesis, May 1, 2004; 25(5): 661 - 668.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Widschwendter, H. M. Muller, H. Fiegl, L. Ivarsson, A. Wiedemair, E. Muller-Holzner, G. Goebel, C. Marth, and M. Widschwendter
DNA Methylation in Serum and Tumors of Cervical Cancer Patients
Clin. Cancer Res., January 15, 2004; 10(2): 565 - 571.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Rathi, A. K. Virmani, K. Harada, C. F. Timmons, K. Miyajima, R. J. Hay, D. Mastrangelo, A. Maitra, G. E. Tomlinson, and A. F. Gazdar
Aberrant Methylation of the HIC1 Promoter Is a Frequent Event in Specific Pediatric Neoplasms
Clin. Cancer Res., September 1, 2003; 9(10): 3674 - 3678.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Toyooka, K. O. Toyooka, K. Miyajima, J. L. Reddy, M. Toyota, U. G. Sathyanarayana, A. Padar, M. S. Tockman, S. Lam, N. Shivapurkar, et al.
Epigenetic Down-Regulation of Death-associated Protein Kinase in Lung Cancers
Clin. Cancer Res., August 1, 2003; 9(8): 3034 - 3041.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Yuan, R. Z. Luo, S. Fujii, L. Wang, W. Hu, M. Andreeff, Y. Pan, M. Kadota, M. Oshimura, A. A. Sahin, et al.
Aberrant Methylation and Silencing of ARHI, an Imprinted Tumor Suppressor Gene in which the Function Is Lost in Breast Cancers
Cancer Res., July 15, 2003; 63(14): 4174 - 4180.
[Abstract] [Full Text] [PDF]

Home page
 J Natl Cancer Inst MonogrHome page
S. S. Wang and A. Hildesheim
Chapter 5: Viral and Host Factors in Human Papillomavirus Persistence and Progression
J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 35 - 40.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. Segura-Pacheco, C. Trejo-Becerril, E. Perez-Cardenas, L. Taja-Chayeb, I. Mariscal, A. Chavez, C. Acuna, A. M. Salazar, M. Lizano, and A. Duenas-Gonzalez
Reactivation of Tumor Suppressor Genes by the Cardiovascular Drugs Hydralazine and Procainamide and Their Potential Use in Cancer Therapy
Clin. Cancer Res., May 1, 2003; 9(5): 1596 - 1603.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Kuzmin, L. Liu, R. Dammann, L. Geil, E. J. Stanbridge, S. P. Wilczynski, M. I. Lerman, and G. P. Pfeifer
Inactivation of RAS Association Domain Family 1A Gene in Cervical Carcinomas and the Role of Human Papillomavirus Infection
Cancer Res., April 15, 2003; 63(8): 1888 - 1893.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M.-Y. Yang, T.-C. Liu, J.-G. Chang, P.-M. Lin, and S.-F. Lin
JunB gene expression is inactivated by methylation in chronic myeloid leukemia
Blood, April 15, 2003; 101(8): 3205 - 3211.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. V. Harden, Y. Tokumaru, W. H. Westra, S. Goodman, S. A. Ahrendt, S. C. Yang, and D. Sidransky
Gene Promoter Hypermethylation in Tumors and Lymph Nodes of Stage I Lung Cancer Patients
Clin. Cancer Res., April 1, 2003; 9(4): 1370 - 1375.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Rathi, A. K. Virmani, J. O. Schorge, K. J. Elias, R. Maruyama, J. D. Minna, S. C. Mok, L. Girard, D. A. Fishman, and A. F. Gazdar
Methylation Profiles of Sporadic Ovarian Tumors and nonmalignant Ovaries from High-Risk Women
Clin. Cancer Res., November 1, 2002; 8(11): 3324 - 3331.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
K. Y. K. Chan, H. Ozcelik, A. N. Y. Cheung, H. Y. S. Ngan, and U.-S. Khoo
Epigenetic Factors Controlling the BRCA1 and BRCA2 Genes in Sporadic Ovarian Cancer
Cancer Res., July 15, 2002; 62(14): 4151 - 4156.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.